Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Drugs alphabetical "j", total number of products: 54
Reg.‑No.
Product
Composition
A
|
B
|
C
|
D
|
E
|
F
|
G
|
H
|
I
|
J
|
K
|
L
|
M
|
N
|
O
|
P
|
Q
|
R
|
S
|
T
|
U
|
V
|
W
|
X
|
Y
|
Z
|
0-9
1 - 54
65867
IP
CI
Jadenu 180 mg
Coated tablets: Deferasiroxum 180 mg
G
65867
IP
CI
Jadenu 360 mg
Coated tablets: Deferasiroxum 360 mg
G
65867
IP
CI
Jadenu 90 mg
Coated tablets: Deferasiroxum 90 mg
G
62126
IP
CI
Jakavi 10 mg
Tablets: Ruxolitinibum 10 mg
G
62126
IP
CI
Jakavi 15 mg
Tablets: Ruxolitinibum 15 mg
G
62126
IP
CI
Jakavi 20 mg
Tablets: Ruxolitinibum 20 mg
G
62126
IP
CI
Jakavi 5 mg
Tablets: Ruxolitinibum 5 mg
G
69722
Jakavi 5 mg/ml
Solution (oral): Ruxolitinibum 5 mg/ml
G
58450
IP
CI
Janumet 50/1000
Coated tablets: 2 Active Agents
G
58450
IP
CI
Janumet 50/500
Coated tablets: 2 Active Agents
G
58450
IP
CI
Janumet 50/850
Coated tablets: 2 Active Agents
G
65052
IP
CI
Janumet XR 100 mg/1000 mg
Coated tablets: 2 Active Agents
G
65052
IP
CI
Janumet XR 50 mg/1000 mg
Coated tablets: 2 Active Agents
G
65052
IP
CI
Janumet XR 50 mg/500 mg
Coated tablets: 2 Active Agents
G
57863
IP
CI
Januvia 100 mg
Coated tablets: 2 Active Agents
G
57863
IP
CI
Januvia 25 mg
Coated tablets: Sitagliptinum 25 mg
G
57863
IP
CI
Januvia 50 mg
Coated tablets: Sitagliptinum 50 mg
G
63227
IP
CI
Jardiance 10 mg
Coated tablets: Empagliflozinum 10 mg
G
63227
IP
CI
Jardiance 25 mg
Coated tablets: Empagliflozinum 25 mg
G
65570
IP
Jardiance Met 12.5 mg/1000 mg
Coated tablets: 2 Active Agents
G
65570
IP
Jardiance Met 12.5 mg/500 mg
Coated tablets: 2 Active Agents
G
65570
IP
Jardiance Met 12.5 mg/850 mg
Coated tablets: 2 Active Agents
G
65570
IP
CI
Jardiance Met 5 mg/1000 mg
Coated tablets: 2 Active Agents
G
65570
IP
CI
Jardiance Met 5 mg/500 mg
Coated tablets: 2 Active Agents
G
65570
IP
CI
Jardiance Met 5 mg/850 mg
Coated tablets: 2 Active Agents
G
53148
IP
CI
Jarsin 300
Dragées: Hyperici Herbae Extractum Methanolicum Siccum 300 mg
G
57009
IP
CI
Jarsin 450
Coated tablets: Hyperici Herbae Extractum Methanolicum Siccum 450 mg
G
62688
IP
CI
Jaydess 10 mcg/24 Stunden
Intrauterines Wirkstofffreisetzungssystem: Levonorgestrelum 13.5 mg
G
68733
IP
Jaypirca 100 mg
Coated tablets: Pirtobrutinibum 100 mg
G
68733
IP
CI
Jaypirca 50 mg
Coated tablets: Pirtobrutinibum 50 mg
G
67183
IP
CI
Jeanine
Dragées: 2 Active Agents
G
68023
IP
Jemperli 500 mg/10 ml
Concentrate for infusion: Dostarlimabum 500mg / 10ml
G
62492
IP
CI
Jentadueto 2.5 mg/1000 mg
Coated tablets: 2 Active Agents
G
62492
IP
CI
Jentadueto 2.5 mg/500 mg
Coated tablets: 2 Active Agents
G
62492
IP
CI
Jentadueto 2.5 mg/850 mg
Coated tablets: 2 Active Agents
G
61543
IP
Jevtana 60 mg/1.5 ml
solution à diluer et solvant pour solution pour perfusion: Cabazitaxelum 60 mg
G
61315
IP
CI
Jext 150 Mikrogramm
Injektionslösung im Fertigpen: Adrenalinum 150 µg
G
61315
IP
CI
Jext 300 Mikrogramm
Injektionslösung im Fertigpen: Adrenalinum 300 µg
G
38482
CI
JHP Rödler Japanisches Heilpflanzenöl
Tropfen zum Einnehmen: Menthae Arvensis Aetheroleum Partim Mentholum Depletum (Mentha Arvensis var. Piperascens Malinv. ex Holmes, Aetheroleum) 899.82 mg/ml
G
65676
IP
CI
Jinarc 15 mg
Tablets: Tolvaptanum 15 mg
G
65676
IP
CI
Jinarc 30 mg
Tablets: Tolvaptanum 30 mg
G
65676
IP
CI
Jinarc 45 mg + 15 mg
Tablets: Tolvaptanum 45 mg
Tablets: Tolvaptanum 15 mg
G
65676
IP
CI
Jinarc 60 mg + 30 mg
Tablets: Tolvaptanum 60 mg
Tablets: Tolvaptanum 30 mg
G
65676
IP
CI
Jinarc 90 mg + 30 mg
Tablets: Tolvaptanum 90 mg
Tablets: Tolvaptanum 30 mg
G
66882
IP
Jivi 1000 IE
Lyophilisate and solvent: Damoctocogum alfa Pegolum 1000 UI
G
66882
IP
Jivi 2000 IE
Lyophilisate and solvent: Damoctocogum alfa Pegolum 2000 UI
G
66882
IP
Jivi 3000 IE
Lyophilisate and solvent: Damoctocogum alfa Pegolum 3000 UI
G
66999
IP
Jorveza 0.5 mg
Schmeltabletten: Budesonidum
G
66999
IP
CI
Jorveza 1 mg
Melting tablets: Budesonidum 1 mg
G
69950
Jubbonti 60 mg/ml
Injection solution in prefilled syringe: Denosumabum 60 mg
G
67466
IP
CI
Juliette
Coated tablets: 2 Active Agents
G
66790
IP
CI
Juluca 50 mg
Coated tablets: 2 Active Agents
G
68411
IP
CI
Jylamvo 2 mg/ml
Solution (oral): Methotrexatum 2 mg/ml
G
69173
IP
Jynneos
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
